Literature DB >> 1937754

Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product.

P F Mühlradt1, H Quentmeier, E Schmitt.   

Abstract

The capacity of Mycoplasma fermentans-derived high-molecular-weight material (MDHM) to generate cytolytic T cells from mitogen-stimulated murine thymocytes was studied in detail. The role of MDHM and the involvement of monokines and lymphokines resulting from the addition of MDHM to thymocyte cultures were examined in complete and adherent cell-depleted culture systems by the addition of neutralizing monoclonal antibodies against interleukin-2 (IL-2), IL-4, and IL-6 and in reconstitution experiments with recombinant mediators. The data presented here suggest that MDHM is crucial only in the first phase of a reaction sequence beginning with the stimulation of adherent accessory cells and resulting in the synthesis of IL-1 and IL-6. The lymphokines IL-2 and, primarily, IL-4 are required in a second step which, once these lymphokines are formed, can proceed in the absence of MDHM and accessory cells and leads to the formation of cytolytic T cells. The elucidation of the MDHM-induced reaction sequence may be of relevance in view of the hypothetical role of mycoplasmas in rheumatic disease in humans. M. fermentans is an organism capable of infecting humans and in an early report has been discussed as a causative agent for rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937754      PMCID: PMC258983          DOI: 10.1128/iai.59.11.3962-3968.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Proteolysis of the native murine IL 1 beta precursor is required to generate IL 1 beta bioactivity.

Authors:  C Günther; M Röllinghoff; H U Beuscher
Journal:  Immunobiology       Date:  1989-02       Impact factor: 3.144

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.

Authors:  T Hirano; T Matsuda; M Turner; N Miyasaka; G Buchan; B Tang; K Sato; M Shimizu; R Maini; M Feldmann
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

4.  IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.

Authors:  M Okada; M Kitahara; S Kishimoto; T Matsuda; T Hirano; T Kishimoto
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

5.  Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.

Authors:  S J Hopkins; M Humphreys; M I Jayson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

6.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

7.  DNA synthesis in CD4- and CD8-positive cells in synovial fluid of patients with reactive and rheumatoid arthritis.

Authors:  D C Nordström
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  Capacities of a newly established thymic stromal cell clone to express Ia antigens and to produce interleukin-6, colony-stimulating factor, and thymic stroma-derived T-cell growth factor.

Authors:  M Ogata; H Matsubara; Y Takai; H Kosaka; T Katagiri; H Sano; K Ishimura; H Fujita; T Hamaoka; H Fujiwara
Journal:  J Leukoc Biol       Date:  1989-01       Impact factor: 4.962

9.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

10.  B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.

Authors:  J D Pfeifer; D T McKenzie; S L Swain; R W Dutton
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  9 in total

1.  Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.

Authors:  James P Fabisiak; Fei Gao; Robyn G Thomson; Robert M Strieter; Simon C Watkins; James H Dauber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-02       Impact factor: 5.464

2.  Effects of Mycoplasma fermentans incognitus on differentiation of THP-1 cells.

Authors:  L Reyes; M K Davidson; L C Thomas; J K Davis
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits.

Authors:  P F Mühlradt; U Schade
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 4.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

6.  Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.

Authors:  P F Mühlradt; M Frisch
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

7.  Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells.

Authors:  J G Krueger; J T Wolfe; R T Nabeya; V P Vallat; P Gilleaudeau; N S Heftler; L M Austin; A B Gottlieb
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

8.  Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

9.  The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation.

Authors:  Alexei Christodoulides; Neha Gupta; Vahe Yacoubian; Neil Maithel; Jordan Parker; Theodoros Kelesidis
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 6.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.